InvestorsHub Logo

Hawk05

10/23/19 7:23 PM

#202290 RE: pinhigh #202288

Thanks PH! I would think the open CEO position is Richard Staelin’s if he wants it. Helping BIEL get FDA approval for RecoveryRX and hopefully Full Body for ActiPatch he would deserve to be given the opportunity.

But I don’t have all the facts so it just a guess.

Hawk05

10/23/19 9:56 PM

#202305 RE: pinhigh #202288

Three comments from the Medscape article....

Rachel Rosenfeld Health Business/Administration4 hours ago
As this is OTC, there is no insurance coverage. What does it cost? Unfortunately, many people with chronic pain are not working and can not afford out of pocket costs for devices.

Jan Hempstead| Registered Nurse (RN) 9 hours ago
I use a similar PEMF device called OSKA that is much more expensive because it is not disposable after the 7 days or 720 hours of use. It is rechargeable and can be moved to body parts that are affected. I have Ehlers-Danlos syndrome with daily dislocations and subluxations with significant muscle spasms and cannot tolerate any pain medications, even NSAIDS, due to systemic mast cell disease. This PEMF device has allowed me to function at a tolerable pain level.

Investigating alternative pain therapies for patients unable to tolerate any standard pain medication is important.


Dr. James Marshall| Internal Medicine 11 hours ago
Fascinating and eye opening. Certainly larger and better structured studies are warranted but at the very least, it belongs in the can't hurt, might help pile especially with the current opioid crisis.